PubRank

Seung Up Kim

Author PubWeight™ 96.20‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan). Hepatology 2011 1.87
2 Applicability of BCLC stage for prognostic stratification in comparison with other staging systems: single centre experience from long-term clinical outcomes of 1717 treatment-naïve patients with hepatocellular carcinoma. Liver Int 2012 1.79
3 Number of target lesions for EASL and modified RECIST to predict survivals in hepatocellular carcinoma treated with chemoembolization. Clin Cancer Res 2012 1.67
4 The accuracy of noninvasive methods in predicting the development of hepatocellular carcinoma and hepatic decompensation in patients with chronic hepatitis B. J Clin Gastroenterol 2012 1.63
5 Reversing the silencing of reporter sodium/iodide symporter transgene for stem cell tracking. J Nucl Med 2005 1.59
6 Revision and update on clinical practice guideline for liver cirrhosis. Korean J Hepatol 2012 1.47
7 Performance of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B: a meta-analysis. PLoS One 2012 1.43
8 Usefulness of FibroScan for detection of early compensated liver cirrhosis in chronic hepatitis B. Dig Dis Sci 2008 1.35
9 Current consensus and guidelines of contrast enhanced ultrasound for the characterization of focal liver lesions. Clin Mol Hepatol 2013 1.35
10 Thrombin-induced oxidative stress contributes to the death of hippocampal neurons in vivo: role of microglial NADPH oxidase. J Neurosci 2005 1.28
11 Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population. Liver Int 2013 1.27
12 Human neural stem cell transplantation reduces spontaneous recurrent seizures following pilocarpine-induced status epilepticus in adult rats. Brain Res 2004 1.17
13 Normal controlled attenuation parameter values: a prospective study of healthy subjects undergoing health checkups and liver donors in Korea. Dig Dis Sci 2014 1.16
14 Liver stiffness measurement using acoustic radiation force impulse (ARFI) elastography and effect of necroinflammation. Dig Dis Sci 2012 1.14
15 Prospective validation of FibroTest in comparison with liver stiffness for predicting liver fibrosis in Asian subjects with chronic hepatitis B. PLoS One 2012 1.12
16 Microglia expressing interleukin-13 undergo cell death and contribute to neuronal survival in vivo. Glia 2004 1.09
17 Clinical applications of transient elastography. Clin Mol Hepatol 2012 1.07
18 Prospective comparison of prognostic values of modified Response Evaluation Criteria in Solid Tumours with European Association for the Study of the Liver criteria in hepatocellular carcinoma following chemoembolisation. Eur J Cancer 2012 1.06
19 Brain transplantation of genetically engineered human neural stem cells globally corrects brain lesions in the mucopolysaccharidosis type VII mouse. J Neurosci Res 2003 1.05
20 Prognostic value of the 7th edition of the AJCC staging system as a clinical staging system in patients with hepatocellular carcinoma. Eur J Cancer 2011 1.03
21 Clinical application of liver stiffness measurement using transient elastography in chronic liver disease from longitudinal perspectives. World J Gastroenterol 2013 1.02
22 Partial virological response to entecavir in treatment-naive patients with chronic hepatitis B. Antivir Ther 2011 1.02
23 Clinical characteristics and treatment outcomes of hepatocellular carcinoma with inferior vena cava/heart invasion. Anticancer Res 2011 1.01
24 Prospective validation of ELF test in comparison with Fibroscan and FibroTest to predict liver fibrosis in Asian subjects with chronic hepatitis B. PLoS One 2012 1.00
25 How many valid measurements are necessary to assess liver fibrosis using FibroScan® in patients with chronic viral hepatitis? An analysis of subjects with at least 10 valid measurements. Yonsei Med J 2012 1.00
26 Anti-hepatitis A virus seroprevalence among patients with chronic viral liver disease in Korea. Eur J Gastroenterol Hepatol 2007 0.99
27 Comprehensive analysis of time- and dose-dependent patterns of gene expression in a human mesenchymal stem cell line exposed to low-dose ionizing radiation. Oncol Rep 2008 0.97
28 Characterization of focal liver masses using acoustic radiation force impulse elastography. World J Gastroenterol 2013 0.97
29 Hepatogastric fistula caused by direct invasion of hepatocellular carcinoma after transarterial chemoembolization and radiotherapy. Korean J Hepatol 2010 0.97
30 Clinical features of acute viral hepatitis B in Korea: a multi-center study. Korean J Hepatol 2011 0.97
31 ATP released from beta-amyloid-stimulated microglia induces reactive oxygen species production in an autocrine fashion. Exp Mol Med 2007 0.96
32 Early on-treatment predictions of clinical outcomes using alpha-fetoprotein and des-gamma-carboxy prothrombin responses in patients with advanced hepatocellular carcinoma. J Gastroenterol Hepatol 2012 0.96
33 Clinical characteristics and prognosis of hepatocellular carcinoma with different sets of serum AFP and PIVKA-II levels. Eur J Gastroenterol Hepatol 2012 0.95
34 Efficacy of sorafenib monotherapy versus sorafenib-based loco-regional treatments in advanced hepatocellular carcinoma. PLoS One 2013 0.93
35 Non-invasive assessment of changes in liver fibrosis via liver stiffness measurement in patients with chronic hepatitis B: impact of antiviral treatment on fibrosis regression. Hepatol Int 2010 0.93
36 Non-invasive assessment of liver fibrosis: the gap between ideal and real. J Gastroenterol Hepatol 2011 0.93
37 Prediction of recurrence after curative resection of hepatocellular carcinoma using liver stiffness measurement (FibroScan®). Ann Surg Oncol 2012 0.93
38 Prognostic significance of the worst grade in hepatocellular carcinoma with heterogeneous histologic grades of differentiation. J Gastroenterol Hepatol 2013 0.92
39 Clinical application of transient elastography in patients with chronic viral hepatitis receiving antiviral treatment. Liver Int 2014 0.92
40 Migration of human neural stem cells toward an intracranial glioma. Exp Mol Med 2008 0.92
41 Prognostic factors and 10-year survival in patients with hepatocellular carcinoma after curative hepatectomy. J Gastrointest Surg 2011 0.91
42 Prognostic value of α-fetoprotein and des-γ-carboxy prothrombin responses in patients with hepatocellular carcinoma treated with transarterial chemoembolization. BMC Cancer 2013 0.90
43 Gastroduodenal complications after concurrent chemoradiation therapy in patients with hepatocellular carcinoma: endoscopic findings and risk factors. Int J Radiat Oncol Biol Phys 2010 0.90
44 Non-invasive assessment of liver fibrosis: time to move from cross-sectional studies to longitudinal ones. J Gastroenterol Hepatol 2010 0.89
45 Evolution from WHO to EASL and mRECIST for hepatocellular carcinoma: considerations for tumor response assessment. Expert Rev Gastroenterol Hepatol 2014 0.88
46 Normal liver elasticity values using acoustic radiation force impulse imaging: a prospective study in healthy living liver and kidney donors. J Gastroenterol Hepatol 2012 0.88
47 Role of surgical resection for multiple hepatocellular carcinomas. World J Gastroenterol 2013 0.88
48 Combination treatment of localized concurrent chemoradiation therapy and transarterial chemoembolization in locally advanced hepatocellular carcinoma with intrahepatic metastasis. Cancer Chemother Pharmacol 2012 0.88
49 Antiviral efficacies of currently available rescue therapies for multidrug-resistant chronic hepatitis B. Clin Mol Hepatol 2013 0.88
50 Response rates to medical treatments and long-term clinical outcomes of nonsurgical patients with intestinal Behçet disease. J Clin Gastroenterol 2010 0.87
51 [A case of hepaticoduodenal fistula development after transarterial chemoembolization in patient with hepatocellular carcinoma]. Korean J Gastroenterol 2011 0.87
52 Silk amino acids improve physical stamina and male reproductive function of mice. Biol Pharm Bull 2010 0.86
53 Adjuvant hepatic arterial infusional chemotherapy with 5-fluorouracil and cisplatin after curative resection of hepatocellular carcinoma. Oncology 2011 0.86
54 Survival of hepatocellular carcinoma patients may be improved in surveillance interval not more than 6 months compared with more than 6 months: a 15-year prospective study. J Clin Gastroenterol 2013 0.86
55 Impact of spontaneous hepatocellular carcinoma rupture on recurrence pattern and long-term surgical outcomes after partial hepatectomy. World J Surg 2014 0.86
56 Inhibition of tumour angiogenesis and growth by small hairpin HIF-1α and IL-8 in hepatocellular carcinoma. Liver Int 2013 0.85
57 Long-term outcomes of chronic hepatitis B virus infection in the era of antiviral therapy in Korea. J Gastroenterol Hepatol 2014 0.85
58 Thrombin induces IL-10 production in microglia as a negative feedback regulator of TNF-alpha release. Neuroreport 2002 0.85
59 Role of splenectomy in patients with hepatocellular carcinoma and hypersplenism. ANZ J Surg 2012 0.84
60 Risk assessment of clinical outcomes in Asian patients with chronic hepatitis B using enhanced liver fibrosis test. Hepatology 2014 0.84
61 Optimal time for restoring the reliability of liver stiffness measurement in patients with chronic hepatitis B experiencing acute exacerbation. J Clin Gastroenterol 2012 0.84
62 Surgical resection after down-staging of locally advanced hepatocellular carcinoma by localized concurrent chemoradiotherapy. Ann Surg Oncol 2014 0.84
63 Combined measurement of preoperative α-fetoprotein and des-γ-carboxy prothrombin predicts recurrence after curative resection in patients with hepatitis-B-related hepatocellular carcinoma. Int J Cancer 2012 0.84
64 Antiviral efficacy of lamivudine versus entecavir in patients with hepatitis B virus-related advanced hepatocellular carcinoma. J Gastroenterol Hepatol 2012 0.83
65 Transient elastography-based risk estimation of hepatitis B virus-related occurrence of hepatocellular carcinoma: development and validation of a predictive model. Onco Targets Ther 2013 0.83
66 Clinical outcomes and prognostic factors of patients with advanced hepatocellular carcinoma treated with sorafenib as first-line therapy: a Korean multicenter study. J Gastroenterol Hepatol 2014 0.82
67 Overexpression of midbrain-specific transcription factor Nurr1 modifies susceptibility of mouse neural stem cells to neurotoxins. Neurosci Lett 2002 0.82
68 Acoustic radiation force impulse elastography: a better option for patients with extrahepatic cholestasis. Eur J Gastroenterol Hepatol 2012 0.82
69 Combination of preS deletions and A1762T/G1764A mutations in HBV subgenotype C2 increases the risk of developing HCC. Intervirology 2011 0.82
70 Leflunomide increases the risk of silent liver fibrosis in patients with rheumatoid arthritis receiving methotrexate. Arthritis Res Ther 2012 0.81
71 Risk assessment of liver-related events using transient elastography in patients with chronic hepatitis B receiving entecavir. J Clin Gastroenterol 2014 0.81
72 Lower incidence of hepatocellular carcinoma and cirrhosis in hepatitis C patients with sustained virological response by pegylated interferon and ribavirin. Dig Dis Sci 2014 0.81
73 Use of Wisteria Floribunda Agglutinin-Positive Human Mac-2 Binding Protein in Assessing Risk of Hepatocellular Carcinoma Due to Hepatitis B Virus. Medicine (Baltimore) 2016 0.81
74 A case of hepatocellular carcinoma within hepatocellular adenoma in a non-cirrhotic male. Korean J Intern Med 2009 0.81
75 Role for PKC-epsilon in neuronal death induced by oxidative stress. Biochem Biophys Res Commun 2004 0.81
76 Clinical usefulness of double biomarkers AFP and PIVKA-II for subdividing prognostic groups in locally advanced hepatocellular carcinoma. Liver Int 2013 0.81
77 Abnormal liver stiffness assessed using transient elastography (Fibroscan®) in HIV-infected patients without HBV/HCV coinfection receiving combined antiretroviral treatment. PLoS One 2013 0.81
78 "Normal" liver stiffness values differ between men and women: a prospective study for healthy living liver and kidney donors in a native Korean population. J Gastroenterol Hepatol 2012 0.81
79 Long-term changes of liver stiffness values assessed using transient elastography in patients with chronic hepatitis B receiving entecavir. Liver Int 2013 0.81
80 Quasispecies and pre-existing drug-resistant mutations of hepatitis B virus in patients with chronic hepatitis B. Gut Liver 2013 0.80
81 Can transient elastography be used for the management of chronic hepatitis B patients? Liver Int 2012 0.80
82 Normal enhanced liver fibrosis (ELF) values in apparently healthy subjects undergoing a health check-up and in living liver donors in South Korea. Liver Int 2013 0.79
83 Discordance between liver biopsy and FibroTest in assessing liver fibrosis in chronic hepatitis B. PLoS One 2013 0.79
84 Black esophagus associated with alcohol abuse. Gut Liver 2008 0.79
85 Maintaining remission in lamivudine-resistant patients with a virological response to adefovir add-on lamivudine after stopping lamivudine therapy. Liver Int 2014 0.78
86 Liver stiffness-based model for prediction of hepatocellular carcinoma in chronic hepatitis B virus infection: comparison with histological fibrosis. Liver Int 2014 0.78
87 Probability-based interpretation of liver stiffness measurement in untreated chronic hepatitis B patients. Dig Dis Sci 2015 0.78
88 Orthotopic liver transplantation after the combined use of locoregional therapy and sorafenib for advanced hepatocellular carcinoma. Onco Targets Ther 2013 0.78
89 Acoustic radiation force impulse elastography is useful to exclude nonliver-related ascites. Eur J Gastroenterol Hepatol 2011 0.78
90 Clinical course of virologic breakthrough after emergence of YMDD mutations in HBeAg-positive chronic hepatitis B. Intervirology 2008 0.78
91 Chasing after novel non-invasive markers to identify advanced fibrosis in NAFLD. Clin Mol Hepatol 2013 0.78
92 Risk Assessment of Hepatocellular Carcinoma Using Transient Elastography Vs. Liver Biopsy in Chronic Hepatitis B Patients Receiving Antiviral Therapy. Medicine (Baltimore) 2016 0.77
93 Amyloid precursor protein processing is separately regulated by protein kinase C and tyrosine kinase in human astrocytes. Neurosci Lett 2002 0.77
94 Prognostic value of the combined use of transient elastography and fibrotest in patients with chronic hepatitis B. Liver Int 2014 0.77
95 Community-acquired vs. nosocomial spontaneous bacterial peritonitis in patients with liver cirrhosis. Hepatogastroenterology 2015 0.77
96 Acoustic Radiation Force Impulse Measurement in Renal Transplantation: A Prospective, Longitudinal Study With Protocol Biopsies. Medicine (Baltimore) 2015 0.77
97 Predictors of refractory ascites development in patients with hepatitis B virus-related cirrhosis hospitalized to control ascitic decompensation. Yonsei Med J 2013 0.77
98 Partial virological response to adefovir add-on lamivudine rescue therapy in patients with lamivudine-resistant chronic hepatitis B. Digestion 2013 0.77
99 Intravenous administration of human mesenchymal stem cells after noise- or drug-induced hearing loss in rats. Acta Otolaryngol 2012 0.77
100 The use of health functional foods in gastrointestinal cancer patients. Clin Nutr Res 2013 0.76
101 Toll-like receptor polymorphisms are not associated with liver cirrhosis in hepatitis B virus infected Korean patients. Hepatogastroenterology 2011 0.76
102 Non-invasive prediction of development of hepatocellular carcinoma using transient elastography in patients with chronic liver disease. Expert Rev Gastroenterol Hepatol 2014 0.76
103 Acute variceal hemorrhage in patients with liver cirrhosis: weekend versus weekday admissions. Yonsei Med J 2012 0.75
104 Transient elastography in real practice: a time for action? J Gastroenterol Hepatol 2012 0.75
105 Subclinical Ascites Does Not Affect the Long-term Prognosis in Hepatitis B Virus-related Cirrhosis Patients Receiving Antivirals. J Clin Gastroenterol 2016 0.75
106 Corrigendum: Improvement of Liver Fibrosis after Long-Term Antiviral Therapy Assessed by Fibroscan in Chronic Hepatitis B Patients With Advanced Fibrosis. Am J Gastroenterol 2017 0.75
107 Use of Wisteria Floribunda Agglutinin-Positive Human Mac-2 Binding Protein in Assessing Risk of Hepatocellular Carcinoma Due to Hepatitis B Virus. Medicine (Baltimore) 2016 0.75
108 Optimal timing of combining sorafenib with locoregional treatments in patients with advanced hepatocellular carcinoma. Eur J Gastroenterol Hepatol 2013 0.75
109 [Inflammatory Hepatic Adenoma]. Korean J Gastroenterol 2015 0.75